In a previous post, we discussed the history of regenerative medicine from the 8th century B.C. through the present day. This exciting field has developed from its speculative roots into a broad and diverse industry with many subcategories and hundreds of therapies in development. In this post, we’ll talk about where exactly Cook MyoSite’s Autologous Muscle Derived Cells (AMDC) technology fits under the modern regenerative medicine umbrella.
Topics: regenerative medicine, clinical development, clinical trials, regulatory
This article was originally published to RegMedNet on June 16th, 2020.
Topics: regenerative medicine, clinical development, clinical trials, regulatory
In this webinar, originally presented via RegMedNet on April 15th, 2021, the Regulatory experts at Cook MyoSite walk attendees through the company's experience applying for the FDA's Regenerative Medicine Advanced Therapy (RMAT) designation, receiving an initial rejection, and reapplying to successfully obtain the designation.
Topics: regenerative medicine, clinical development, clinical trials, regulatory
What is a clinical trial? In short, clinical trials are where new medical research and people meet.
Topics: regenerative medicine, clinical trials
Stem cells have been the center of medical intrigue for much of the last few decades. During this time, the differences between the popular and the scientific conceptions of what is and isn’t a stem cell have grown. Often, the public's understanding of stem cells is far narrower than how the term is applied by scientists. What is a stem cell? Does Cook MyoSite work with stem cells?
Topics: regenerative medicine, stem cells
Since ancient times, humans have told stories about the body’s natural ability to regenerate. In the 8th century B.C., the Greek poet Hesiod wrote about the regenerative capabilities of the Titan Prometheus’s liver:
Topics: regenerative medicine
Cook MyoSite
105 Delta Drive
Pittsburgh, PA 15238
Ph: 855.867.9368
Fax: 412.967.9729
